| A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection (NCT02836470) | Palisade Bio | 2019-10-01 |
| Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT (NCT04123392) | Nanfang Hospital, Southern Medical University | 2019-10-01 |
| Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA) (NCT04110275) | Angde Biotech Pharmaceutical Co., Ltd. | 2019-10-01 |
| Evaluation of Dronabinol For Acute Pain Following Traumatic Injury (NCT03928015) | CommonSpirit Health | 2019-10-01 |
| A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas (NCT03632317) | University of Michigan Rogel Cancer Center | 2019-10-01 |
| Starting the Conversation (NCT04107714) | University of Ulm | 2019-10-01 |
| Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation (NCT04063462) | Tianjin Medical University Cancer Institute and Hospital | 2019-10-01 |
| Cannabidiol for Alcohol Use Disorder (NCT03904849) | Medical University of South Carolina | 2019-10-01 |
| Rucaparib Maintenance Therapy in Advanced Cervical Cancer (NCT03795272) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2019-10-01 |
| Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck (NCT04129320) | MacroGenics | 2019-10-01 |
| Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer (NCT03994107) | Peking Union Medical College | 2019-10-01 |
| Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study. (NCT04061395) | University Medical Center Groningen | 2019-10-01 |
| A Monocentric Study Assessing the Efficacy of the Nitrosylated Hemoglobin as Biomarker for Detecting the Development of a Cardiovascular Complication During or After Surgery (NCT03994900) | Université Catholique de Louvain | 2019-10-01 |
| The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms (NCT04405193) | Melva Louisa | 2019-10-01 |
| Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE) (NCT04057040) | Protagonist Therapeutics, Inc. | 2019-10-01 |
| A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC (NCT03817658) | The First Affiliated Hospital of Zhengzhou University | 2019-10-01 |
| Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity (NCT04082715) | Second Affiliated Hospital of Wenzhou Medical University | 2019-10-01 |
| A Study of FF-10501-01 in Combination with Azacitidine in Patients with Myelodysplastic Syndrome (NCT03486353) | Fujifilm Pharmaceuticals U.S.A., Inc. | 2019-10-01 |
| Chemoradiotherapy in Unresectable Esophageal Cancer (NCT04278287) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-10-01 |
| Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD) (NCT04027361) | Tris Pharma, Inc. | 2019-10-01 |
| Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran (NCT04197323) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-10-01 |
| Botulinum Toxin Injection for Functional Popliteal Artery Entrapment Syndrome (NCT03631966) | Stanford University | 2019-10-01 |
| Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis (NCT03940235) | European Institute of Oncology | 2019-10-01 |
| PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (NCT03837457) | miRagen Therapeutics, Inc. | 2019-10-01 |
| Ocrelizumab for Psychosis by Autoimmunity (NCT03971487) | The Methodist Hospital Research Institute | 2019-10-01 |
| Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy (NCT04531163) | Al-Azhar University | 2019-10-01 |
| The Efficacy and Safety of Temozolomide in Patients With MPPGL (NCT05858177) | Peking Union Medical College Hospital | 2019-10-01 |
| Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell Carcinoma (NCT04054518) | Tiago Biachi | 2019-10-01 |
| AraC for Newly Diagnosed Adult Langerhans Cell Histiocytosis (NCT04121819) | Peking Union Medical College Hospital | 2019-10-01 |
| Stem Cell Therapy in Non-IschEmic Non-treatable Dilated CardiomyopathiEs II: a Pilot Study (NCT03797092) | JKastrup | 2019-10-01 |
| Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients (NCT03792763) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2019-09-30 |
| MTT for Children With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders (NCT04132427) | Arizona State University | 2019-09-30 |
| Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (NCT04082364) | MacroGenics | 2019-09-30 |
| A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) (NCT03841448) | Alnylam Pharmaceuticals | 2019-09-30 |
| Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion (NCT03613740) | University of Guadalajara | 2019-09-30 |
| A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation (NCT03608501) | Takeda | 2019-09-30 |
| Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers (NCT03761914) | Sellas Life Sciences Group | 2019-09-30 |
| Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (NCT04001517) | EIP Pharma Inc | 2019-09-30 |
| CuATSM Compared With Placebo for Treatment of ALS/MND (NCT04082832) | Collaborative Medicinal Development Pty Limited | 2019-09-30 |
| A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma (NCT04082936) | IGM Biosciences, Inc. | 2019-09-30 |
| RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus (NCT04159974) | University of Cologne | 2019-09-30 |
| Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer (NCT03766607) | Korean South West Oncology Group | 2019-09-30 |
| Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma (NCT03927222) | Mustafa Khasraw, MBChB, MD, FRCP, FRACP | 2019-09-30 |
| A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) (NCT03989414) | Celgene | 2019-09-30 |
| Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS) (NCT03799874) | Brigham and Women's Hospital | 2019-09-30 |
| Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients (NCT04102852) | San Giovanni Addolorata Hospital | 2019-09-30 |
| Bright Light Therapy in the Treatment of Non-seasonal Bipolar Depression (NCT03396744) | Assistance Publique - Hôpitaux de Paris | 2019-09-30 |
| A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer (NCT04095390) | Jinming Yu | 2019-09-30 |
| The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy (NCT04088929) | Pure Green | 2019-09-30 |
| A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma (NCT02939807) | Medical University of South Carolina | 2019-09-30 |
| AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma (NCT04058145) | Massachusetts General Hospital | 2019-09-30 |
| Carfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCL (NCT03891355) | Fondazione Italiana Linfomi - ETS | 2019-09-30 |
| A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients (NCT04042324) | Rockwell Medical Technologies, Inc. | 2019-09-30 |
| SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC (NCT04106180) | Fudan University | 2019-09-30 |
| A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) (NCT04093570) | Taiho Oncology, Inc. | 2019-09-30 |
| A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma (NCT03970616) | AVEO Pharmaceuticals, Inc. | 2019-09-30 |
| A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial Hypercholesterolemia (NCT04031742) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-09-29 |
| PCSK9 Inhibitor Treatment for Patients With SPG5 (NCT04101643) | First Affiliated Hospital of Fujian Medical University | 2019-09-29 |
| Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense (NCT03974178) | Drugs for Neglected Diseases | 2019-09-29 |
| MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (NCT03962543) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2019-09-29 |
| Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure (NCT04049045) | Christian Schulze | 2019-09-29 |
| A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma (NCT03505554) | University of Milano Bicocca | 2019-09-28 |
| A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2) (NCT03987295) | Alector Inc. | 2019-09-27 |
| MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas (NCT03697512) | International Extranodal Lymphoma Study Group (IELSG) | 2019-09-27 |
| Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study (NCT03617666) | University College, London | 2019-09-27 |
| Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo (NCT04103060) | Dermavant Sciences GmbH | 2019-09-27 |
| Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients (NCT04117477) | Children's Hospital Medical Center, Cincinnati | 2019-09-27 |
| FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC (NCT05217069) | Ludwig-Maximilians - University of Munich | 2019-09-27 |
| Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia (NCT04010968) | French Innovative Leukemia Organisation | 2019-09-27 |
| Evaluation of AP-002 in Patients With Solid Tumors (NCT04143789) | Altum Pharmaceuticals INC | 2019-09-27 |
| OCS-01 in Treating Inflammation and Pain in Post-cataract Patients (NCT04130802) | Oculis | 2019-09-27 |
| First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM) (NCT04083534) | Regeneron Pharmaceuticals | 2019-09-26 |
| Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP (NCT06727357) | European Institute of Oncology | 2019-09-26 |
| Reduced Dose-density of Denosumab for Unresectable GCTB (NCT03620149) | European Organisation for Research and Treatment of Cancer - EORTC | 2019-09-26 |
| A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies (NCT04042558) | Centre Francois Baclesse | 2019-09-26 |
| Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients (NCT04097821) | Novartis Pharmaceuticals | 2019-09-26 |
| Single Ascending Dose Study in Participants With LCA10 (NCT03872479) | Editas Medicine, Inc. | 2019-09-26 |
| Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects (NCT03750968) | Paul S. Bernstein | 2019-09-26 |
| Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG (NCT04062656) | University Hospital, Essen | 2019-09-26 |
| Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline (NCT04202263) | State University of New York - Downstate Medical Center | 2019-09-26 |
| A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (NCT04033445) | Janssen Research & Development, LLC | 2019-09-26 |
| Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients (NCT04835883) | Hanyang University Seoul Hospital | 2019-09-26 |
| Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours (NCT03326388) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2019-09-26 |
| Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (NCT03776864) | University of Washington | 2019-09-26 |
| Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury (NCT04051957) | The University of Texas Health Science Center, Houston | 2019-09-26 |
| AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines (NCT04096326) | Allergan | 2019-09-26 |
| Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients (NCT04072198) | Gruppo Oncologico Italiano di Ricerca Clinica | 2019-09-26 |
| Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment (NCT04109963) | University of Calgary | 2019-09-26 |
| A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD (NCT03953079) | Graybug Vision | 2019-09-26 |
| An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) (NCT04113616) | Kartos Therapeutics, Inc. | 2019-09-25 |
| INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma (NCT03837509) | Incyte Corporation | 2019-09-25 |
| Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2) (NCT03915184) | CARsgen Therapeutics Co., Ltd. | 2019-09-25 |
| hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study" (NCT03824691) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-09-25 |
| Functional Endoscopic Sinus Surgery Study (NCT03970655) | University of Florida | 2019-09-25 |
| Platelet-rich Plasma for Eyebrows (NCT04018859) | Northwestern University | 2019-09-25 |
| Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) (NCT03980041) | Infinity Pharmaceuticals, Inc. | 2019-09-25 |
| Montelukast Therapy on Alzheimer's Disease (NCT03991988) | Emory University | 2019-09-25 |
| Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands (NCT04080882) | Galderma R&D | 2019-09-25 |
| Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease (NCT03933904) | University of Pennsylvania | 2019-09-25 |
| A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM) (NCT04062448) | Janssen Pharmaceutical K.K. | 2019-09-25 |